【结 构 式】 |
【分子编号】39982 【品名】5-(4-iodophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine 【CA登记号】 |
【 分 子 式 】C13H13IN2 【 分 子 量 】324.16417 【元素组成】C 48.17% H 4.04% I 39.15% N 8.64% |
合成路线1
该中间体在本合成路线中的序号:(XV)The esterification of 3-(4-imidazolyl)-2(E)-propenoic acid (I) with SOCl2 and methanol gives the methyl ester (II), which is reduced with H2 over Pd/C yielding the propionic ester (III). The reduction of (III) with LiAlH4 affords 3-(4-imidazolyl)-1-propanol (IV), which is treated with N,N-dimethyl chloroformamide to afford 4-(3-hydroxypropyl)-N,N-dimethylimidazole-1-carboxamide (V). The mesylation of (V) with methanesulfonyl chloride to give the corresponding methanesulfonate (VI), which is condensed with alpha-bromo-4-iodotoluene (XII) by means of NH3 and treated with HCl yielding 3-[1-(4-iodobenzyl)imidazol-5-yl]-1-propanol (XIII). The reaction of (XIII) with SOCl2 affords the 3-chloropropyl derivative (XIV), which is cyclized by means of potassium tert-butoxide to give 5-(4-iodobenzyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine (XV). Finally, this compound is condensed with radiolabeled potassium cyanide by means of palladium tetrakis(triphenylphosphine).
【1】 Allentoff, A.J.; et al.; Palladium-catalyzed aryl cynations in radiosynthesis: Synthesis of 14C-labeled fadrozole, a potent aromatase inhibitor. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 49. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27420 | Urocanic acid; (E)-3-(1H-imidazol-4-yl)-2-propenoic acid | 104-98-3 | C6H6N2O2 | 详情 | 详情 |
(II) | 39976 | methyl (E)-3-(1H-imidazol-4-yl)-2-propenoate | C7H8N2O2 | 详情 | 详情 | |
(III) | 39977 | methyl 3-(1H-imidazol-4-yl)propanoate | C7H10N2O2 | 详情 | 详情 | |
(IV) | 21245 | 3-(1H-imidazol-4-yl)-1-propanol | C6H10N2O | 详情 | 详情 | |
(V) | 39978 | 4-(3-hydroxypropyl)-N,N-dimethyl-1H-imidazole-1-carboxamide | C9H15N3O2 | 详情 | 详情 | |
(VI) | 27902 | N,N-dimethyl-4-[3-[(trimethylsilyl)oxy]propyl]-1H-imidazole-1-carboxamide | C12H23N3O2Si | 详情 | 详情 | |
(XII) | 39980 | 1-(bromomethyl)-4-iodobenzene | 16004-15-2 | C7H6BrI | 详情 | 详情 |
(XIII) | 39979 | 3-[1-(4-iodobenzyl)-1H-imidazol-5-yl]-1-propanol | C13H15IN2O | 详情 | 详情 | |
(XIV) | 39981 | 5-(3-chloropropyl)-1-(4-iodobenzyl)-1H-imidazole | C13H14ClIN2 | 详情 | 详情 | |
(XV) | 39982 | 5-(4-iodophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine | C13H13IN2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)The protection of 3-(1H-imidazol-4-yl)-1-propanol (I) according to known techniques gives (II), which is condensed with 4-iodobenzyl bromide (III) by means of ammonia in acetonitrile, yielding 3-[1-(4-iodobenzyl)-1H-imidazol-5-yl)-1-propanol (IV). The reaction of (IV) with SOCl2 in dichloromethane affords the corresponding chloro derivative (V), which is cyclized by means of LDA and TMEDA in THF, affording 5-(4-iodophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine (VI). Finally, this compound is treated with (14C)-KCN and palladium tetrakis(triphenylphosphine) in refluxing THF.
【1】 Markus, B.; Jones, L.; Duelfer, T.; Ray, T.; Wu, A.; Allentoff, A.J.; Ciszewska, G.; Palladium-catalyzed aryl cyanations with [C-14]KCN: Synthesis of C-14-labelled fadrozole, a potent aromatase inhibitor. J Label Compd Radiopharm 2000, 43, 11, 1075. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21245 | 3-(1H-imidazol-4-yl)-1-propanol | C6H10N2O | 详情 | 详情 | |
(II) | 47910 | N-(tert-butyl)-4-[3-[(trimethylsilyl)oxy]propyl]-1H-imidazole-1-carboxamide | C14H27N3O2Si | 详情 | 详情 | |
(III) | 39980 | 1-(bromomethyl)-4-iodobenzene | 16004-15-2 | C7H6BrI | 详情 | 详情 |
(IV) | 39979 | 3-[1-(4-iodobenzyl)-1H-imidazol-5-yl]-1-propanol | C13H15IN2O | 详情 | 详情 | |
(V) | 39981 | 5-(3-chloropropyl)-1-(4-iodobenzyl)-1H-imidazole | C13H14ClIN2 | 详情 | 详情 | |
(VI) | 39982 | 5-(4-iodophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine | C13H13IN2 | 详情 | 详情 |